Fluorescence PCR · Others
Candida Albicans Nucleic Acid Detection Kit (Fluorescence PCR)
For in vitro qualitative detection of Candida albicans nucleic acid in vaginal discharge and sputum specimens. Assists in the diagnosis of Candida infections in the urogenital and respiratory tracts.
- SKU Code
AENE-FG001A- Approval
- On request
- Product Type
- Assay / Kit
- Status
- Available
For in vitro qualitative detection of Candida albicans nucleic acid in vaginal discharge and sputum specimens. Assists in the diagnosis of Candida infections in the urogenital and respiratory tracts.
| Product type | Assay / Kit |
|---|---|
| Technology platform | Fluorescence PCR |
| Application area | Others |
Epidemiology
Candida species represent the most abundant normal fungal flora in humans. They are widely present in the respiratory, digestive, and urogenital tracts, as well as other sites exposed to the external environment. Usually non-pathogenic, these organisms are considered opportunistic pathogens. The widespread use of immunosuppressants, broad-spectrum antibiotics, cancer radiotherapy, chemotherapy, invasive procedures, and organ transplantation can disrupt the normal microbial balance, leading to Candida infections in the genitourinary and respiratory tracts.
Genitourinary Candida infection can cause Candida vulvovaginitis in women, significantly impacting their quality of life and work. The yearly incidence of genital tract candidiasis is rising; approximately 36% of cases occur in females and 9% in males, with Candida albicans (CA) responsible for roughly 80% of these infections. Fungal infections, particularly those caused by Candida albicans, are a major contributor to hospital-acquired mortality, accounting for about 40% of ICU patient infections. Pulmonary fungal infections are the most common among visceral fungal diseases, and their prevalence is increasing annually. Early diagnosis and identification of pulmonary fungal infections are therefore clinically critical.
Work Flow
Option 1: The recommended extraction reagent is the Sample Release Reagent.
Option 2: The recommended extraction reagents are the Viral DNA/RNA Kit and an Automatic Nucleic Acid Extractor.
| SKU code | AENE-FG001A |
|---|---|
| Storage | ≤-18℃ |
| Shelf-life | 12 months |
| Specimen Type | Vaginal discharge, Sputum |
| Ct | ≤38 |
| CV | ≤5.0% |
| LoD | 1×10 3 Copies/mL |
| Specificity | There is no cross-reactivity with other genitourinary tract infection pathogens such as Candida tropicalis, Candida glabrata, Trichomonas vaginalis, Chlamydia trachomatis, Ureaplasma urealyticum, Neisseria gonorrhoeae, Group B Streptococcus, herpes simplex virus type 2 and other respiratory pathogen infection pathogens such as adenovirus, Mycobacterium tuberculosis, Klebsiella pneumoniae, measles virus and normal human sputum samples |
| Applicable Instruments | Applied Biosystems 7500 Real-Time PCR System QuantStudio®5 Real-Time PCR Systems SLAN-96P Real-Time PCR Systems LightCycler®480 Real-Time PCR system LineGene 9600 Plus Real-Time PCR Detection System MA-6000 Real-Time Quantitative Thermal Cycler BioRad CFX96 Real-Time PCR System BioRad CFX Opus 96 Real-Time PCR System |
| Approval | On request |
|---|---|
| Documents | Datasheet, IFU, SDS, COA / conformance, origin, and export documents where available |
FAQ
What should be confirmed before quotation?
Sample context, collection method, and extraction workflow should be confirmed before final kit selection.
Which documents can be requested?
Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.
Can the format be adjusted for different workflows?
Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.
Inquiry
Send the essentials for a useful first reply.
Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-FG001A to the right quote or sample discussion.